| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 06/23/2004 | CN1507435A Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 06/23/2004 | CN1507434A Novel 4-anilinoquinoline-3-carboxamides compound |
| 06/23/2004 | CN1506359A Coumarin amide derivative and its prepn, medicinal composition and use |
| 06/23/2004 | CN1154642C Pyranone compounds useful to treat retroviral infections |
| 06/22/2004 | US6753432 Process for the preparation of thiazolidinedione derivatives |
| 06/22/2004 | US6753347 Intermediates for the synthesis of benzimidazole derivatives and a process for the preparation thereof |
| 06/22/2004 | US6753340 Autoimmune disease, antiarthritic agents, antiallergens, anticancer agents |
| 06/22/2004 | US6753331 Heterocyclic derivatives which inhibit factor Xa |
| 06/22/2004 | CA2122022C Anti-explosion pads and their method of use |
| 06/17/2004 | WO2004050655A1 Polymorphic forms of ziprasidone and its hydrochloride |
| 06/17/2004 | WO2004050654A1 Synthesis of pyrrolidine compound and salt thereof |
| 06/17/2004 | WO2004050636A2 IMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 06/17/2004 | WO2004050633A1 Pesticidal 1-ayl-3-amidoxime-pyrazole derivatives |
| 06/17/2004 | WO2004050619A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease |
| 06/17/2004 | WO2004050613A2 2-substituted-3-propenamide derivatives and methods of using the same |
| 06/17/2004 | WO2004050089A1 Epothilone analogs for site specific delivery in the treatment of proliferative diseases |
| 06/17/2004 | WO2004050082A1 The novel coumarin-amide derivatives and its preparation, said drug composition and its use |
| 06/17/2004 | WO2004050036A2 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
| 06/17/2004 | WO2004050035A2 Benzimidazoles and analogs thereof as antivirals |
| 06/17/2004 | WO2004050030A2 Anti-sickling agents |
| 06/17/2004 | WO2004050024A2 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 06/17/2004 | WO2004049797A2 Pesticidal sulphonylaminopyrazoles |
| 06/17/2004 | WO2004043463A3 Sulfonamides |
| 06/17/2004 | WO2004021997A3 Inhibitors of fungal invasion |
| 06/17/2004 | WO2004014316A3 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 06/17/2004 | WO2003105781A3 Ophthalmic compositions for treating ocular hypertension |
| 06/17/2004 | US20040116718 Therapy for breast cancer; plant extracts |
| 06/17/2004 | US20040116710 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 06/17/2004 | US20040116706 Therapeutic ureas |
| 06/17/2004 | US20040116699 Melanocortin receptor agonists |
| 06/17/2004 | US20040116509 Antiviral agent; reducing the activity of viral polymerase; 3-(4-Chloro-2,5-dimethyl-benzenesulfonylamino)-5-(4-chloro-phenyl)-thiophene-2-carboxylic acid for example |
| 06/17/2004 | US20040116507 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 06/17/2004 | US20040116491 Therapy for infections; autoimmune diseases; vision defects; asthma:eating disorders; cardiovascular disorders; liver disorders; antiallergens; antiinflammatory agents; antiulcer agnets |
| 06/17/2004 | US20040116486 Metalloproteinase inhibitors |
| 06/17/2004 | US20040116485 Broad spectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors |
| 06/17/2004 | US20040116483 Glucagon antagonists/inverse agonists |
| 06/17/2004 | US20040116476 Imidazolidinone compounds |
| 06/17/2004 | US20040116473 useful in the treatment of TGF- beta related disease states including, for example, cancer and fibrotic diseases |
| 06/17/2004 | US20040116465 Novel compounds |
| 06/17/2004 | US20040116454 Pyrazole compounds useful as protein kinase inhibitors |
| 06/17/2004 | US20040116445 Substituted thioacetamides |
| 06/17/2004 | US20040116440 Useful for diagnosis, treatment of male or female sexual dysfunction |
| 06/17/2004 | US20040116439 Serine protease inhibitors |
| 06/17/2004 | US20040116430 Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
| 06/17/2004 | US20040116427 Compounds for inhibition of HIV infection by blocking HIV entry |
| 06/17/2004 | US20040116425 Prenylation inhibitors and methods of their synthesis and use |
| 06/17/2004 | US20040116424 Aryl imidazoles and related compounds as C5a receptor modulators |
| 06/17/2004 | US20040116423 5-Aryltetrazole compounds, compositions thereof, and uses therefor |
| 06/17/2004 | US20040116421 Heterocyclic compounds as antitumor agents with benzimidazole group and morpholine group, triazoline or pyrimidine heterocycles |
| 06/17/2004 | US20040116399 for preventing or treating coagulation disorders |
| 06/17/2004 | US20040116388 triazine compoound inhibitors of enzymes that catalyze phosphoryl transfer and/or that bind ATP/GTP nucleotides |
| 06/17/2004 | US20040116353 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 06/17/2004 | US20040116326 Medicinal composition containing 1,3-thiazine derivative |
| 06/17/2004 | US20040115473 Polythiophenes, furan resins, polypyrroles, organonitrogen polymers |
| 06/17/2004 | DE10256405A1 New 4-substituted quinoline derivatives, useful for treating bacterial infections, optionally including additional ring nitrogens |
| 06/17/2004 | DE10247233A1 New 4-substituted quinoline derivatives, useful for treating bacterial infections, optionally including additional ring nitrogens |
| 06/17/2004 | CA2508325A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease |
| 06/17/2004 | CA2507624A1 Imidazole-derivatives as factor xa inhibitors |
| 06/16/2004 | EP1428534A1 Benzofurazan derivatives for enhancing glutamatergic synaptic responses |
| 06/16/2004 | EP1428533A2 Use of thiazolidine- or pyrrolidine-derivatives of aminoacids as antihyperglycemic agents |
| 06/16/2004 | EP1427720A1 3-substituted-4-pyrimidone derivatives |
| 06/16/2004 | EP1427709A1 3-substituted-4-pyrimidone derivatives |
| 06/16/2004 | EP1427423A1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 06/16/2004 | EP1427421A1 2,4-disubstituted pyrimidinyl derivatives for use as anticancer agents |
| 06/16/2004 | EP1427416A2 3-glyoxlylamideindoles for treating cancer |
| 06/16/2004 | EP1427408A2 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$g(a) CONVERTING ENZYME (TACE) |
| 06/16/2004 | EP1355646A4 Muscarinic receptor agonists |
| 06/16/2004 | EP1351958B1 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 06/16/2004 | EP1282616B1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatement of pain |
| 06/16/2004 | EP1265889B1 Medicaments against viral diseases |
| 06/16/2004 | EP1219173B1 Insecticides and acaricides |
| 06/16/2004 | EP1200429B1 1-cycloalkylpyrazoyl-benzoyl derivatives |
| 06/16/2004 | EP0983243B1 Novel quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain |
| 06/16/2004 | EP0977725B1 New fatty acid derivatives |
| 06/16/2004 | EP0960104B1 N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors |
| 06/16/2004 | EP0823423B1 1,4-disubstituted piperidine derivatives |
| 06/16/2004 | EP0807105B1 Pyridopyrimidones, quinolines and fused n-heretocycles as bradykinin antagonists |
| 06/16/2004 | CN1505626A Novel benzylpiperidine compound |
| 06/16/2004 | CN1505625A Triazole compounds useful in treating diseases associated with unwanted cytokine activity |
| 06/16/2004 | CN1505624A Piperazino-derivatives and their use as pde4 inhibitor |
| 06/16/2004 | CN1505613A Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppar-gamma binding agents |
| 06/16/2004 | CN1153766C Nitroketone compound, its preparing process and pharmaceutical composition containing same |
| 06/15/2004 | US6750349 Superior gastrokinetic properties |
| 06/15/2004 | US6750348 Protective effects against infection by hiv through binding to chemokine receptors, including cxcr4 and ccr5;n-(2-pyridinylmethyl)-n'-(2-(phenylureido)ethyl)-n'-(5,6,7,8-tetrahydro-8-quinolinyl)-1,4-benzenedimethanamine |
| 06/15/2004 | US6750342 Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
| 06/15/2004 | US6750338 Process for making 5-substituted pyrazoles |
| 06/15/2004 | US6750228 Uncontrolled breakdown of connective tissue by metalloproteases is a feature of many pathological conditions |
| 06/15/2004 | US6750218 Inhibitory activity on phosphorylation of platelet-derived growth factor (pdgf) receptor useful for the treatment of cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis |
| 06/15/2004 | US6750024 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds |
| 06/10/2004 | WO2004048544A2 Ca ix-specific inhibitors |
| 06/10/2004 | WO2004048392A1 Oxazolidinone and / or isoxazoline derivatives as antibacterial agents |
| 06/10/2004 | WO2004048372A1 Thia-epothilone derivatives for the treatment of cancer |
| 06/10/2004 | WO2004048371A1 Indolyl derivatives |
| 06/10/2004 | WO2004048368A2 Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors |
| 06/10/2004 | WO2004048365A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 06/10/2004 | WO2004048349A1 Farnesoid x receptor agonists |
| 06/10/2004 | WO2004048343A1 Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 06/10/2004 | WO2004048334A1 Phenyl substituted piperidine compounds for use as ppar activators |
| 06/10/2004 | WO2004048332A1 Isoindoline derivative |
| 06/10/2004 | WO2004047837A2 Beta-blockers having antioxidant and nitric oxide-donor activity |